Showing results (221-230 of 331) with videos related to

Sort By:
Pageof 34
JAMA Oncology|March 25, 2021
Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected MelanomaJ Randall Patrinely, Rebecca Johnson, Aleigha R Lawless, et al.
Oncoimmunology|February 25, 2021
A multicenter characterization of hepatitis associated with immune checkpoint inhibitorsJ Randall Patrinely, Ben McGuigan, Sunandana Chandra, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2024
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastasesInes Pires da Silva, Isabel Li, Selma Ugurel, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancerChristine M Lovly, Kelli L Boyd, Paula I Gonzalez-Ericsson, et al.
Cancer|January 29, 2019
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanomaPatrick A Ott, Anna C Pavlick, Douglas B Johnson, et al.
Circulation|August 8, 2019
Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-OncologyMarc P Bonaca, Benjamin A Olenchock, Joe-Elie Salem, et al.
Nature Medicine|October 13, 2022
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trialRichard D Carvajal, Marcus O Butler, Alexander N Shoushtari, et al.
Melanoma Research|September 27, 2022
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case seriesJessica Louise Smith, Alexander M Menzies, Justine V Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanomaLea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2019
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant MelanomaInês Pires da Silva, Kevin Y X Wang, James S Wilmott, et al.
Pageof 34